Gautam N, Mishra A. Formulation and Characterization of Repaglinide Chitosan Nanoparticles for the Treatment of Diabetes Mellitus Type II. Cur Res Pharm Sci [Internet]. 2019Jan.8 [cited 2026Apr.21];8(4):270-7. Available from: https://crpsonline.com/index.php/crps/article/view/3